X
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence to learn the language of life and transform how we treat disease. The company seeks to rethink the drug discovery and development process from end-to-end by bringing together leading talent across three core areas: machine learning research to better understand biology, expansive data generation to power new models, and robust therapeutic product development to treat disease. Xaira is headquartered in the San Francisco Bay Area.
Investor insights
Funding rounds participated in
$1B sweet spot round size
Investor type
Privately Held
Basic info
Industry
Biotechnology Research
Sectors
Biotechnology Research
Date founded
2023
Funding rounds raised
Total raised
$1B
from 3 investors over 1 rounds
X
Xaira Therapeutics raised $1B on May 23, 2024
Investors: ARCH Venture Partners, Foresite Capital and + 11 Other investors